Value-based care providers have increasingly collaborated with health insurers to try and keep medically complex patients out ...
Hosted on MSN14d
MGRM: Monogram’s Potential for 2025 Commercialization of its mBôs Total Knee Arthroplasty Robotic System Supports Price Target of $6.00.MGRM READ THE FULL MGRM RESEARCH REPORT Regulatory Update On February 26, 2025, Monogram (NASDAQ:MGRM) announced an update regarding its 510(k) premarket filing submission to the FDA for the company's ...
NASHVILLE, Tenn. and HOUSTON, March 4, 2025 /PRNewswire/ -- Monogram Health—the nation's leading value-based multispecialty provider of in-home, evidence-based care for patients with multiple ...
Completed all Supplemental Testing and has Submitted its Formal Response to the FDA’s Additional Information Request (AIR) ...
Company has Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR) Investigator Meeting and Clinical Trial Training Held at the ...
Company has Completed all Supplemental Testing and has Submitted its Formal Response to the FDA’s Additional Information Request (AIR) ...
Company has Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR) AUSTIN, TX / ACCESS Newswire / February 26, 2025 / Monogram ...
In August 2024, Monogram announced a strategic collaboration with Shalby Limited (NSE:SHALBY) ("Shalby"), a global multi-specialty hospital chain and one of India's leading orthopedic hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback